
Bovetas Pharmaceuticals Private Limited
About Bovetas Pharmaceuticals Private Limited
Data last updated:
Bovetas Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 03 May 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74140DL2013PTC251547. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sandeep and Rattan Singh.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at B – 443/1 G No. – 3 Kh No. – 401 Meet Nagar Delhi Meet Nagar, Delhi, India – 110094.
As per the financials filed for FY 2019, the company reported a revenue of ₹45,000, a decline of 90% compared to the previous year. For the same year it recorded a net loss of ₹12,129 (net margin -27%) and EBITDA of -₹12,129 (EBITDA margin -27%). Revenue has declined at a compounded annual rate (CAGR) of 70% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Bovetas Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressB – 443/1 G No. – 3 Kh No. – 401 Meet Nagar Delhi Meet Nagar, Delhi, India – 110094
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Bovetas Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Bovetas Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Bovetas Pharmaceuticals Private Limited, buy the company report.
Financials of Bovetas Pharmaceuticals Private Limited
FY 2019 filings availableBovetas Pharmaceuticals Private Limited reported revenue of ₹45,000 (down 90% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 70% over three years, including a 90% fall in the latest year. EBITDA fell 818% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹12,129 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹12,129 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -27% | ||||
| Net Profit Margin | -27% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bovetas Pharmaceuticals Private Limited, buy the company report.
Board of directors of Bovetas Pharmaceuticals Private Limited
Bovetas Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sandeep | Director | 03 May 2013 | 13 Years 6 Months | Current |
| Rattan Singh | Director | 03 May 2013 | 13 Years 6 Months | Current |
Auditor
Bovetas Pharmaceuticals Private Limited is audited by SUMIT R.K. & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SUMIT R.K. & CO. | FY 2017 | 029211N |
Shareholding
The shareholding of Bovetas Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Bovetas Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Bovetas Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bovetas Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Bovetas Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Bovetas Pharmaceuticals Private Limited, buy the company report.
Recent activity
Bovetas Pharmaceuticals Private Limited has 2 board changes on record since 2013: 2 appointments. The latest: Rattan Singh was appointed as Director on 03 May 2013.
Frequently asked questions
Bovetas Pharmaceuticals is an active private limited company based in Delhi, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 03 May 2013 (13+ years old) and is registered under CIN U74140DL2013PTC251547.
Bovetas Pharmaceuticals has 2 current directors:
- Sandeep - Director
- Rattan Singh - Director
The latest financial statements of Bovetas Pharmaceuticals on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from 2015 are in the company report.
No. Bovetas Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Bovetas Pharmaceuticals is U74140DL2013PTC251547. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bovetas Pharmaceuticals was incorporated on 03 May 2013, making it 13+ years old. It is registered with the Registrar of Companies, Delhi.
Rattan Singh was appointed as Director on 03 May 2013. Sandeep was appointed as Director on 03 May 2013.
The registered office of Bovetas Pharmaceuticals is at B – 4431 G No. – 3 Kh No. – 401 Meet Nagar Delhi Meet Nagar, Delhi, India – 110094.
Bovetas Pharmaceuticals operates in the chemicals industry, in the medicinal chemical and botanical products segment.
The compliance status of Bovetas Pharmaceuticals is compliant as of 11 August 2026. The company is actively filing with the Registrar of Companies.

